Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
Key Highlights
- ➤Abbott intends tax-free separation of Nutrition business into publicly traded company by end of 2027
- ➤New Nutrition company projected at approximately $8.5 billion annual sales
- ➤Abbott expects approximately $42 billion sales after separation
- ➤Abbott says separation will not impact 2026 or planned 2027 guidance
- ➤Abbott shareholders will receive shares in both Abbott and Nutrition company
Expert Statements
Robert B. Ford, Chairman and chief executive officer of Abbott
“As we continue to shape Abbott for the future, this separation will benefit both companies, setting each one up for maximum success in its respective market.”
Robert B. Ford, Chairman and chief executive officer of Abbott
“Our Nutrition business has a unique opportunity to capitalize on the growing demand for healthy nutrition, and it will be better positioned as an independent company to more effectively direct its strategic resources across its priorities.”
Robert B. Ford, Chairman and chief executive officer of Abbott
“At the same time, Abbott's core higher-growth, innovation-driven portfolio of medical devices, diagnostics and established medicines has compelling growth opportunities to improve the health and lives of people around the world.”
Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company PR Newswire
* Separation will unlock potential of both companies to pursue distinct growth and value-creation strategies * The new Nutrition company will be a global leader in the rapidly growing healthy nutrition market, with a portfolio of iconic, category-leading brands, including Similac, PediaSure, Pedialyte, Glucerna and Ensure * Abbott will have accelerated sales growth and an expanded margin profile * Abbott intends to separate its Nutrition business through a tax-free distribution to Abbott shareholders * Separation expected to be completed by the end of 2027 ABBOTT PARK, Ill., Oct. 21, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, today announced its intention to separate its Nutrition business into an independent, publicly traded company that will be a global leader in the rapidly expanding healthy nutrition market with approximately $8.5 billion in annual sales and a portfolio of iconic brands.
Get started
Create a free account to read the full story.